Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Patel Dinesh V Ph D sold 125,000 Protagonist Therapeutics, Inc. shares (Form 4)
Traded Sep 8 to Sep 10, 2026 · Filed Sep 10, 2026
From Sep 8 to Sep 10, 2026, Patel Dinesh V Ph D (Director, President and CEO) sold 125,000 Protagonist Therapeutics, Inc. shares at an average US$145.92 for US$18.2M under a trading plan, leaving 522,968 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 125,000 shares
- Price
- US$145.92 average (US$144.10 to US$146.18)
- Value
- US$18.2M
- Holding after
- 522,968 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | Option exercise | 54,174 | US$21.58 | 577,142 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 54,174 | US$145.87 | 522,968 | Direct |
| Sep 9, 2026 | Common Stock | Option exercise | 63,548 | US$21.58 | 586,516 | Direct |
| Sep 9, 2026 | Common Stock | Sale | 63,548 | US$146.18 | 522,968 | Direct |
| Sep 10, 2026 | Common Stock | Option exercise | 7,278 | US$21.58 | 530,246 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 7,278 | US$144.10 | 522,968 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Patel Dinesh V Ph D
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026
- Form 4/A · Patel Dinesh V Ph D · May 14, 2026
- Form 4 · Patel Dinesh V Ph D · Apr 24, 2026
- Form 4 · Ali Asif · Oct 2, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Waddill William D. · Jun 25, 2026
- Form 4 · Waddill William D. · Jun 11, 2026